Table 1.
Baseline and clinical characteristics.
Patients, n 11 | Sex-Sparing RARC |
---|---|
Age, year, mean (±SD) | 47.1 (13) |
BMI, mean (±SD) | 23.1 (3.3) |
ASA score, n (%) | |
1 | 4 (36.4) |
2 | 6 (54.6) |
3 | 1 (9) |
4 | - |
Preoperative eGFR, mL/min, mean (±SD) | 84 (26.8) |
Preoperative Hgb, g/dL, mean (±SD) | 12.6 (1.9) |
Neoadjuvant Chemotherapy, n (%) | 4 (36.3) |